Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US
This purchase order is to service US hospitals through BioPorto’s distribution relationship with Roche Diagnostics.
June 27, 2025
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
This purchase order is to service US hospitals through BioPorto’s distribution relationship with Roche Diagnostics.